EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection

Karolína Škopová iD, Jana Holubová iD, Barbora Bočková, Eva Slivenecká iD, João Melo Santos de Barros, Ondřej Staněk iD, Peter Šebo iD

mSphere · 2025

DOI: 10.1128/msphere.00639-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Karolína Škopová und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia. Hauptthemen laut MEDLINE: Pertussis Vaccine, Whooping Cough, Bordetella pertussis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Revabiotech SE, Institute of Microbiology of the Czech Academy of Sciences, Ministry of Education Youth and Sports of the Czech Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pertussis resurged over the last decade in most countries that replaced the traditional whole-cell pertussis vaccines (wP) by the less reactogenic acellular pertussis vaccines (aP). The aP vaccines induce a Th2-polarized immune response and by a yet unknown mechanism hamper the clearance of Bordetella pertussis from infected nasopharyngeal mucosa. The aP-induced pertussis toxin-neutralizing antibodies effectively prevent the life-threatening pertussis pneumonia in infants, but aP-elicited immunity fails to prevent infection of nasopharyngeal mucosa and transmission of B. pertussis . In contrast, the more reactogenic traditional wP vaccines, alike natural infection, elicit a broad antibody response and trigger a Th1/Th17-polarized T cell immunity. We tackled here the reactogenicity of the conventional wP vaccines by genetic modification of the Fim2 and Fim3-producing B. pertussis strains used for wP vaccine manufacturing. Mutations were introduced into the genomes of vaccine strains (i) to reduce the TLR4 signaling potency of the lipid A of B. pertussis lipooligosaccharide (Δ lgm B), (ii) eliminate the enzymatic (immunosuppressive) activity of the pertussis toxin (PtxS1-R9K/E129G), and (iii) ablate the production of the dermonecrotic toxin (Δ dnt ). Experimental alum-adjuvanted wP vaccines prepared from such triply modified bacteria exhibited a reduced pyrogenicity in rabbits and a reduced systemic toxicity in mice, while conferring a comparable protection from B. pertussis infection as the unmodified wP vaccine. IMPORTANCE The occasionally severe adverse reactions associated with some lots of the whole-cell pertussis vaccine (wP) led the industrialized nations to switch to the use of less reactogenic acellular pertussis vaccines that confer shorter-lasting protection. This yielded whooping cough resurgence and large whooping cough outbreaks are currently sweeping throughout European countries, calling for the replacement of the pertussis vaccine component of pediatric hexavaccines by an improved wP vaccine. We show that genetic detoxification of the Bordetella pertussis bacteria used for wP preparation yields a reduced reactogenicity wP vaccine that exhibits a reduced systemic toxicity in mice and reduced pyrogenicity in rabbits, while retaining high immunogenicity and protective potency in the mouse model of pneumonic infection by B. pertussis . This result has now been confirmed in a nonhuman primate model of B. pertussis infection of olive baboons, paving the way for the development of the next generation of pertussis vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pertussis VaccineWhooping CoughBordetella pertussisAnimalsMiceVirulence Factors, BordetellaAntibodies, BacterialFemaleFimbriae ProteinsMice, Inbred BALB CAntigens, Bacterial

Stichwörter der Autor:innen

Bordetella pertussisdermonecrotic toxinimmunogenicitylipooligosaccharidepertussis toxinprotectionreactogenicitywhole-cell vaccinewhooping cough

Substanzen

Pertussis VaccineVirulence Factors, BordetellaAntibodies, BacterialFimbriae Proteinsfim2 protein, Bordetellafim3 protein, BordetellaAntigens, Bacterial

Autor:innen und Institutionen

  • Institute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.

ORCID-Profile: Karolína Škopová, Jana Holubová, Eva Slivenecká, Ondřej Staněk, Peter Šebo

Förderung

  • Revabiotech SE
  • Institute of Microbiology of the Czech Academy of Sciences
  • Ministry of Education Youth and Sports of the Czech Republic

Zitieren

APA

Škopová, K., Holubová, J., Bočková, B., Slivenecká, E., Santos de Barros, J. M., Staněk, O., & Šebo, P. (2025). Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection. mSphere. https://doi.org/10.1128/msphere.00639-24

Vancouver

Škopová K, Holubová J, Bočková B, Slivenecká E, Santos de Barros JM, Staněk O, et al. Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection. mSphere. 2025. doi:10.1128/msphere.00639-24

BibTeX
@article{kopov2025,
  author = {Škopová, Karolína and Holubová, Jana and Bočková, Barbora and Slivenecká, Eva and Santos de Barros, João Melo and Staněk, Ondřej and Šebo, Peter},
  title = {Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.00639-24}
}
Kostenlos starten →